VR Adviser’s Avalo Therapeutics AVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,208	Closed	-$444K	–	38
2023 Q2	$444K	Buy	5,208 +1,041	+25%	+$88.7K	0.07%	30
2023 Q1	$1.75M	Buy	+4,167	New	+$1.75M	0.34%	23